Shareholders

Actual stock price

Trading in shares of Biocartis Group NV on Euronext has been halted since 25 September 2023. No actual stock price can be provided.

Major shareholders

Biocartis Group NV’s shareholder structure, based on the most recent number of shares and transparency notifications of holdings in excess of 3%, is as follows:

SFPI-FPIM (1): 7.18%

JPMorgan Chase & Co (2): 5.26%

Johnson & Johnson Innovation – JJDC, Inc. (3): 4.11%

UBS Group AG (4): 4.49%

Other institutional and retail investors: 78.96%

Notes:

_{(1) SFPI-FPIM is 100% controlled by the Belgian State.}

_{(2) JP Morgan Chase & Co}

_{(3) Johnson & Johnson Innovation-JJDC, Inc., is a wholly owned subsidiary of Johnson & Johnson. Johnson & Johnson is not a controlled entity.}

_{(4) UBS Group AG controls Credit Suisse AG, Credit Suisse (Schweiz) AG and Credit Suisse Asset Management International Holding Ltd, Credit Suisse Asset Management & Investor Services (Schweiz) Holding AG, Credit Suisse Fund Management S.A.}

The Articles of the Association of BIOCARTIS GROUP NV provide for shareholders notification threshold of 3%, 5% or a multiple of 5% (i.e. 10%, 15%, 20% etc) of the total number of existing voting rights. The notification forms can be downloaded from the website of the FSMA. Completed and signed forms should be sent to i nfo@biocartisgroupnv.be.

See hereunder a list of all transparency notifications press releases and transparency notifications forms received to date.